Firefly Neuroscience (AIFF) Shares Outstanding (2010 - 2026)
Firefly Neuroscience (AIFF) posted Shares Outstanding (Entity) of $20.6 million for Q2 2026, up 38.43% on a QoQ basis from $14.9 million in Q1 2026, and up 54.74% year-over-year from $13.3 million in Q2 2025.
Analysis
Firefly Neuroscience (AIFF) Shares Outstanding (2010 - 2026) Analysis & Trends
Firefly Neuroscience has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $20.6 million in Q2 2026.
- On a quarterly basis, Shares Outstanding (Entity) rose 54.74% year-over-year to $20.6 million in Q2 2026; TTM through Jun 2026 was $20.6 million, a 54.74% increase from a year earlier, with the FY2025 full-year figure at $14.0 million, up 113.3% from the prior year.
- Shares Outstanding (Entity) was $20.6 million for Q2 2026 at Firefly Neuroscience, up from $14.9 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $20.6 million in Q2 2026, with the low at $578151.0 in Q1 2022.
- Average Shares Outstanding (Entity) over 5 years is $6.3 million, with a median of $2.9 million recorded in 2023.
- The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) gained 3.52% in 2023, then soared 1640.36% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $638845.0 in 2022, then grew by 5.04% to $671053.0 in 2023, then soared by 875.6% to $6.5 million in 2024, then soared by 113.3% to $14.0 million in 2025, then soared by 47.36% to $20.6 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $20.6 million (Q2 2026), $14.9 million (Q1 2026), and $14.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | 453.00 Mn |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | 65.16 Mn |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | 86.40 Mn |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | 217.50 Mn |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | 262.10 Mn |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | 68.30 Mn |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | 38.03 Mn |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | 43.67 Mn |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | 42.10 Mn |
| 10 | Firefly Neuroscience | 23.25 Mn | 14.03 Mn | 253,000.00 | 20.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.58 Mn |
| Mar 31, 2026 | 16.23 Mn |
| Dec 31, 2025 | 12.44 Mn |
| Sep 30, 2025 | 13.50 Mn |
| Jun 30, 2025 | 12.67 Mn |
| Mar 31, 2025 | 9.96 Mn |
| Dec 31, 2024 | 6.55 Mn |
| Sep 30, 2024 | 7.08 Mn |
| Jun 30, 2024 | 5.19 Mn |
| Mar 31, 2024 | 671,053.00 |
| Dec 31, 2023 | 649,583.00 |
| Sep 30, 2023 | 646,590.00 |
| Jun 30, 2023 | 641,988.00 |
| Mar 31, 2023 | 640,400.00 |
| Dec 31, 2022 | 601,909.00 |
| Sep 30, 2022 | 612,732.00 |
| Jun 30, 2022 | 579,217.00 |
| Mar 31, 2022 | 576,488.00 |
| Dec 31, 2021 | 419,130.00 |
| Sep 30, 2021 | 419,867.00 |